Report: Ten-year strategy to combat cancer 2021-2030 (France)

From Beacon
Revision as of 19:16, 10 December 2025 by Lucas (talk | contribs) (Update categories.)

forpolicymakers francecountry Go back to France page

Primary purpose: To reduce cancer incidence and improve overall health outcomes through enhanced prevention, early detection, and better management of cancer treatments and side effects.

Sponsor, manager or home institution: The French Ministry of Health and Institut National du Cancer.

Type of information: Cancer prevention and management, outlining objectives, action plans, and funding for reducing cancer incidence and improving patient outcomes. It includes strategies on prevention, research enhancements, and integration with national health policies to coordinate and monitor the efforts across the country. screening, quality of life, healthcare costs. Click here to learn more.

Data level: national level.

Cancer areas of interest: C00-D48: All neoplasms. Click here to learn more.

Access to information: Click here to access.

Mouth Throat Oropharynx Nasopharynx Hypopharynx Larynx Salivary glands Lips Tonsils base of tongue Voice box Esophagus Stomach Small intestine Large intestine Colon Rectum Anus Liver Gallbladder Bile ducts Pancreas Lung Trachea Bronchi Pleura Mediastinum Bone Cartilage Osteosarcoma Ewings sarcoma Skin Melanoma Scalp Lips Hands Feet Muscle Fat Tendon Ligament Blood vessels Connective tissue Sarcoma Angiosarcoma Liposarcoma Lobular Breast Nipple Areola Ductal Vulva Vagina Cervix Uterus Ovary Fallopian tubes Endometrium Prostate Testicles Penis Kidney Ureter Bladder Urethra Eye Brain Spinal cord Thyroid gland Parathyroid Adrenal glands Pituitary gland Pancreas Thymus gland Peritoneum Pericardium Retroperitoneum Mesothelium Blood Bone marrow Lymph nodes Spleen Leukemia dataOwner::The French Ministry of Health dataOwner::Institut National du Cancer availableVariable::screening availableVariable::quality of life availableVariable::healthcare costs dataLevel::national level isReport hasCancerType::C00-D48: All neoplasms hasCancerType::C00-C97: All cancer types hasCancerType::C00-C14: Mouth/throat cancers hasCancerType::C15-C26: Digestive system cancers hasCancerType::C30-C39: Lung/chest cancers hasCancerType::C40-C41: Bone cancers hasCancerType::C43-C44: Skin cancers/melanoma hasCancerType::C45-C49: Soft tissue cancer hasCancerType::C50: Breast cancer hasCancerType::C51-C58: Female genitalia cancers hasCancerType::C60-C63: Male genitalia cancer hasCancerType::C64-C68: Urinary system cancers hasCancerType::C69-C72: Eye and brain cancer hasCancerType::C73-C75: Thyroid and other gland cancers hasCancerType::C76-C80: Cancers of unknown or unspecified areas hasCancerType::C81-C96: Cancers of the blood and immune system hasCancerType::C97-C97: Cancers in multiple locations from the start hasCancerType::D00-D09: Early-stage cancers not yet spread hasCancerType::D10-D36: Benign tumour hasCancerType::D37-D48: Growths of uncertain nature hasCancerType::unknown